
Lauren Tochen, MD, of Children's National Hospital, discusses how the first disease-modifying therapy for Alexander disease could change care and diagnosis.

Laura Schiffman Tochen, MD, is a neurologist and director of the Movement Disorders Program and co-director of the Leukodystrophy and Myelin Disorders Program at Children’s National Hospital.

Lauren Tochen, MD, of Children's National Hospital, discusses how the first disease-modifying therapy for Alexander disease could change care and diagnosis.